Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

China Nepstar Prices IPO at 30% Premium to Range

publication date: Nov 9, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Remember market conditions? The blanket excuse that is trotted out whenever any company fails to find investors in an IPO? Well, market conditions are a little dicey at the moment, but China Nepstar  nevertheless managed to price its IPO at $16.20, which was 30% above the proposed range of $11.50 to $13.50. Prospects trump market conditions, again. In very early open market trading, China Nepstar moved another $2.80 higher to $19 per share. More details...

Stock sybmol: (NYSE: NPD)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners